Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Nuvo Declared Winning Bidder to Acquire Commercial Products from Aralez

By Nuevo Pharmaceuticals Inc. | December 3, 2018

Nuvo Pharmaceuticals Inc., a company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, reported that its previously announced acquisition bid for of Aralez’s Canadian business and the Vimovo royalty stream was the most favorable one received and that Aralez will seek court approval for the transaction.

The deal must be approved by the Ontario Superior Court of Justice and the U.S. Bankruptcy Court for the Southern District of New York, which oversee the respective pending proceedings involving Aralez and certain affiliates under Canada’s Companies’ Creditors Arrangement Act (the CCAA) and chapter 11 of the U.S. Bankruptcy Code.  

Subject to such court approvals and other customary closing conditions, closing is anticipated to occur prior to the end of this year.

On September 19, Nuvo announced that it had entered into definitive, binding purchase agreements with Aralez to acquire a portfolio of revenue-generating products, as well as the associated personnel and infrastructure to continue the products’ management and growth, subject to a competitive bidding and auction process approved by the U.S. and Ontario courts. 

Upon closing of the transaction, Nuvo will pay Aralez U $110 million in cash (less the US$4.4 million deposit previously paid and subject to certain working capital adjustments).  

(Source: Nuvo Pharmaceuticals Inc.)

Related Articles Read More >

Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040
Fujifilm Diosynth Technologies
Fujifilm to spend $1.6B to bolster cell culture manufacturing services
Zantac
First Zantac trial slated for February 2023
Bausch Health
Bausch Health gets new chair

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards